--- title: "Cynata Therapeutics (CYP) stock: news and investor profile" url: "https://aibio.space/companies/cynata-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Cynata Therapeutics Limited (ASX: CYP), Australia. The directory classifies it as Biotechnology." --- CYP Cynata Therapeutics Limited ASX · Australia # Cynata Therapeutics (CYP) news Debt Financing · 2026-07-06 ## [Cynata takes $600,000 loan secured against R&D TI rebate](https://aibio.space/news/cynata-takes-600-000-loan-secured-against-r-d-ti-rebate/) The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended. ## Latest Cynata Therapeutics news We have not published a story on Cynata Therapeutics yet. When there is news, it will appear here. ## Cynata Therapeutics at a glance - **Ticker**: CYP - **Listing**: ASX - **Country**: Australia ### Related companies - [Neuroscientific Biopharmaceuticals](https://aibio.space/companies/neuroscientific-biopharmaceuticals/) ASX: NSB - [Terragen Holdings](https://aibio.space/companies/terragen/) ASX: TGH - [Imugene](https://aibio.space/companies/imugene/) ASX: IMU - [Biotron](https://aibio.space/companies/biotron/) ASX: BIT - [Kazia Therapeutics](https://aibio.space/companies/kazia-therapeutics/) NASDAQ: KZIA - [Prescient Therapeutics](https://aibio.space/companies/prescient-therapeutics/) ASX: PTX - [Curvebeam AI](https://aibio.space/companies/curvebeam-ai/) ASX: CVB - [Incannex Healthcare](https://aibio.space/companies/incannex-healthcare/) NASDAQ: IXHL ### Also on ASX - [Recce Pharmaceuticals](https://aibio.space/companies/recce-pharmaceuticals/) RCE - [Medical Developments International](https://aibio.space/companies/medical-developments-international/) MVP - [Epsilon Healthcare](https://aibio.space/companies/epsilon-healthcare/) EPN - [Mesoblast](https://aibio.space/companies/mesoblast/) MSB - [Botanix Pharmaceuticals](https://aibio.space/companies/botanix-pharmaceuticals/) BOT - [Alterity Therapeutics](https://aibio.space/companies/alterity-therapeutics/) ATH ## Questions about Cynata Therapeutics What is the ticker symbol of Cynata Therapeutics? Cynata Therapeutics Limited trades under the ticker CYP on ASX. Where is Cynata Therapeutics listed? Cynata Therapeutics Limited is listed on ASX. Our directory also records these other listings: OTC:CYYNF. Which country or territory is Cynata Therapeutics listed under? Our directory records Cynata Therapeutics Limited under Australia. What does Cynata Therapeutics do? Our directory classifies Cynata Therapeutics Limited as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Cynata Therapeutics? The ISIN recorded for Cynata Therapeutics Limited is AU000000CYP7. Does aibio.space cover Cynata Therapeutics? aibio.space lists Cynata Therapeutics Limited among 2,820 public biotech companies and publishes its news here as stories appear. What is the latest Cynata Therapeutics (CYP) stock news? Our latest story on Cynata Therapeutics, dated Jul 6, 2026: "Cynata takes $600,000 loan secured against R&D TI rebate". The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended. [Source](https://aibio.space/news/cynata-takes-600-000-loan-secured-against-r-d-ti-rebate/). Does Cynata Therapeutics have debt, a term loan or convertible notes? Our latest debt story, dated Jul 6, 2026: "Cynata takes $600,000 loan secured against R&D TI rebate". The $600,000 loan is secured against an expected R&D tax rebate of approximately $1.7m and the company's assets, and falls due by 30 September 2026 unless extended. [Source](https://aibio.space/news/cynata-takes-600-000-loan-secured-against-r-d-ti-rebate/). How long will Cynata Therapeutics's cash last? From our story of Jul 6, 2026: The company says its forecast cash runway now extends beyond the end of the 2027 financial year. [Source](https://aibio.space/news/cynata-takes-600-000-loan-secured-against-r-d-ti-rebate/). Which companies are similar to Cynata Therapeutics? Companies in our directory listed in the same country and business area as Cynata Therapeutics: Neuroscientific Biopharmaceuticals, Terragen Holdings, Imugene, Biotron, Kazia Therapeutics, Prescient Therapeutics. How can I follow Cynata Therapeutics (CYP) news? Press Follow on this page to add Cynata Therapeutics to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Cynata Therapeutics so far, in Debt Financing. ## Investor discussion: Cynata Therapeutics Members talk about Cynata Therapeutics (CYP). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open ASX:CYP on TradingView](https://www.tradingview.com/symbols/ASX-CYP/). ## Listing details Cynata Therapeutics Limited is a public biotech or pharmaceutical company listed on ASX under the ticker CYP, recorded under Australia. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Cynata Therapeutics Limited - **Ticker**: CYP - **Listing**: ASX - **Country or territory**: Australia - **Business scope**: Biotechnology - **ISIN**: AU000000CYP7 - **Other listed symbols**: OTC:CYYNF - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/ASX-CYP/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/cynata-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Cynata Therapeutics (CYP) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/cynata-therapeutics/